Maaike Sohne

Nieuwegein, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial.

Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 18, 2025

The effect of renal impairment and obesity on anti-Xa peak and trough levels in patients receiving therapeutic doses of nadroparin: a comparison with control patients.

The effect of renal impairment and obesity on anti-Xa peak and trough levels in patients receiving therapeutic doses of nadroparin: a comparison with control patients.

Journal: European journal of clinical pharmacology

Published: May 19, 2023

Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial.

Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial.

Journal: EClinicalMedicine

Published: May 14, 2023

Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.

Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.

Journal: Blood cancer journal

Published: March 26, 2023

Variation in hydration use after reinfusion of autologous stem cells in dimethyl sulfoxide (DMSO): a survey of EBMTcenters on behalf of the EBMT Nurses Group.

Variation in hydration use after reinfusion of autologous stem cells in dimethyl sulfoxide (DMSO): a survey of EBMTcenters on behalf of the EBMT Nurses Group.

Journal: Bone marrow transplantation

Published: February 24, 2023

Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study.

Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 04, 2021

Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS.

Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS.

Journal: Blood advances

Published: July 02, 2020

Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit.

Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit.

Journal: Thrombosis research

Published: May 02, 2020

Quality of clinical direct oral anticoagulant prescribing and identification of risk factors for inappropriate prescriptions.

Quality of clinical direct oral anticoagulant prescribing and identification of risk factors for inappropriate prescriptions.

Journal: British journal of clinical pharmacology

Published: October 21, 2019

The relevance of geriatric assessment for older patients receiving palliative chemotherapy.

The relevance of geriatric assessment for older patients receiving palliative chemotherapy.

Journal: Journal of geriatric oncology

Published: December 20, 2018

Hairy cell leukemia presenting with Ecthyma Gangrenosum- a case report.

Hairy cell leukemia presenting with Ecthyma Gangrenosum- a case report.

Journal: BMC infectious diseases

Published: July 31, 2018

Bridging Anticoagulation in Patients with Atrial Fibrillation.

Bridging Anticoagulation in Patients with Atrial Fibrillation.

Journal: The New England journal of medicine

Published: January 07, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026